Introduction {#sec1}
============

Among the chemical modifications of nucleic acids, fluorination has attracted immense interest because of the small size and electronegativity of the fluorine atom and frequently favored pharmacological properties.^[@ref1]−[@ref4]^ While most efforts have focused on nucleosides with fluorine-containing sugars, modification of purine and pyrimidine with fluorine has also yielded useful properties.^[@ref5]^ Of particular note, introduction of fluorine into nucleic acids has enabled structural studies via ^19^F NMR spectroscopy. On the one hand, fluorine is small in size, and it is possible to predict conformational differences with these modified nucleic acids; on the other hand, ^19^F is the only stable fluorine isotope with a large gyromagnetic ratio, and fluorine chemical shifts are quite sensitive to conformational changes. These features allow for the monitoring of conformational changes in nucleic acids using ^19^F NMR spectroscopy.^[@ref6]^ Of particular interest, Fujimoto and co-workers demonstrated that incorporation of 5-trifluoromethyl-2′-deoxycytidine into oligonucleotides allowed for the tracking of B-/Z-DNA transition by ^19^F NMR spectroscopy.^[@ref7]^ In the present work, we wish to report the synthesis of 5-fluoro-2′-deoxycytidine (FdC **5**) and its incorporation into oligonucleotides through the phosphoramidite chemistry-based solid-phase synthesis, and subsequent study of DNA handedness transition, that is, B- and Z-DNA, using ^19^F NMR spectroscopy.

Results and Discussion {#sec2}
======================

Synthesis of 5-Fluoro-2′-deoxycytidine **5** {#sec2.1}
--------------------------------------------

While FdC was previously synthesized from 5-fluoro-2′-deoxyuridine (FdU **1**) in 56% yield via a tetrazolide intermediate,^[@ref8]^ the chemistry requires the use of 1*H*-tetrazole, which can be limited in practical synthesis because of the thermal sensitivity of 1*H*-tetrazole and consequent shipping restrictions.

Conversion of uracil nucleosides to the corresponding cytosine nucleosides is well documented in the literature. Two common approaches involve the formation of uracil 4-arylether (such as 4-(*p*-nitrophenyl)ether **2**) or 4-triazolide **3**.^[@ref9]−[@ref11]^ Attempted syntheses of FdC **5** from FdU **1** through intermediates **2** or **3**, however, were unsuccessful, leading only to the recovery of starting material **1** ([Scheme [1](#sch1){ref-type="scheme"}](#sch1){ref-type="scheme"}).

![Reagents and conditions: (i). TMSCl, 1-methylpyrrolidine, *p*-nitrophenol, (CF~3~CO)~2~O, CH~3~CN, 0 °C, 4 h; (ii). Ac~2~O, C~5~H~5~N, r.t., 12 h; (iii). POCl~3~, 1,2,3-triazole (for **3a**, 2 h) or 1,2,4-triazole (for **3b**, 5 h); (iv). TMSCl, 1-methylpyrrolidine, 2,4,6-trimethylphenol, (CF~3~CO)~2~O, CH~3~CN, 0 °C, 4 h; v). aq. NH~4~OH, 65 °C, 24 h.](ao9b02461_0004){#sch1}

Conversion of FdU **1** into the transiently protected 2,4,6-trimethylphenyl ether **4** followed by aminolysis, on the other hand, led to the isolation of the desired FdC **5** in 50% yield, with recovery of the starting material FdU **1** in 36% yield.

Choice of the Protecting Group for the Exocyclic Amine of FdC {#sec2.2}
-------------------------------------------------------------

While Fritz and co-workers^[@ref8]^ incorporated FdC into oligonucleotides using *N*-benzoyl-protected FdC (*N*-Bz-FdC **6b**), it was found by us that *N*-Bz-FdC is unstable under the acidic conditions required for the detritylation reaction in solid-phase synthesis. Thus, *N*-acetyl-**6a**, *N*-benzoyl-**6b**, and *N*-pivaloyl-FdC **6c** were prepared ([Scheme [2](#sch2){ref-type="scheme"}](#sch2){ref-type="scheme"}) and evaluated for their suitability for solid-phase synthesis.

![Reagents and conditions: (i). a. TMSCl, C~5~H~5~N; b. acyl chloride; c. aq. NEt~3~.](ao9b02461_0005){#sch2}

In order to incorporate FdC into oligonucleotides, a suitable protecting group for exocyclic amine is required. Thus, the stability of *N*-acyl FdC **6** under acidic and basic conditions was evaluated. As detritylation reactions in solid-phase synthesis are typically carried out by the treatment with di- or trichloroacetic acid (DCA and TCA, respectively), the stability of *N*-4-protected FdC under these conditions is crucial. Such an *N*-4-acyl protecting group should also ensure the stability of the oligonucleotide during the cleavage and deprotection stages of solid-phase synthesis, typically under alkaline conditions. In addition, the deprotection conditions should not lead to structural modifications of oligonucleotides.

As solutions of DCA and TCA are the most commonly used in the detritylation step of solid-phase synthesis of oligonucleotides, the stability of *N*-acyl-FdC **6** was determined in 3% solutions of each acid in methanol. Using an aqueous solution of KF sealed in a capillary insert as an NMR internal standard, the progress of decomposition, if any, was measured by the ratio of integrals of the two ^19^F signals in ^19^F NMR at appropriate intervals.

It was found that *N*-Bz-FdC **6b** and *N*-Piv-FdC **6c** decompose instantaneously in DCA and TCA ([Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}), making *N*-benzoyl and pivaloyl groups unsuitable for solid-phase synthesis. *N*-Ac-FdC **6a**, on the other hand, was found to be more stable, with a half-life of 4.13 h in 3% TCA, but stable in DCA after 24 h. As such, *N*-Ac-FdC **6a** is compatible with the detritylation conditions used in solid-phase synthesis, where the exposure time to TCA is as little as 20 s per cycle on a 1 μmol scale.^[@ref12]^

###### Stability of *N*-Acyl-FdC under Acidic Conditions

  substance            acid (3% in MeOH)   stability
  -------------------- ------------------- -----------------------
  *N*-Bz-FdC **6b**    TCA                 instant decomposition
  *N*-Bz-FdC **6b**    DCA                 instant decomposition
  *N*-Piv-FdC **6c**   TCA                 instant decomposition
  *N*-Piv-FdC **6c**   DCA                 instant decomposition
  *N*-Ac-FdC **6a**    TCA                 4.13 h (half-life)
  *N*-Ac-FdC **6a**    DCA                 stable after 24 h

Next, the lability of the *N*-acyl-protecting groups for FdC under basic conditions was determined by HPLC experiments. Thus, *N*-acyl-FdC **6** was incubated in appropriate alkaline solutions containing a suitable internal standard. Aliquots were withdrawn at appropriate intervals for HPLC analysis. The ratios of peak areas of the internal standard and *N*-acyl-FdC were used to determine the half-life of each *N*-acyl protecting group under respective alkaline conditions.

As can be seen in [Table [2](#tbl2){ref-type="other"}](#tbl2){ref-type="other"}, *N*-Bz-FdC **6b** undergoes deglycosylation at 55 °C at pH 11. *N*-Piv-FdC **6c**, however, is quite stable at pH 9 and 11 but almost completely deprotected in concentrated aqueous ammonium hydroxide at room temperature in 5 min. *N*-Ac-FdC **6a** is more labile than *N*-Piv-FdC **6c**, with a half-life of 51.3 and 21.8 h at pH 9 and 11, respectively, and virtually completely deprotected in concentrated aqueous ammonium hydroxide at room temperature in 5 min. To our surprise, *N*-Ac-FdC **6a** was deprotected by methanol quite effectively, with a half-life of 26.7 h at room temperature. Exposure to ethanol, propanol, and butanol, however, did not lead to deacetylation of *N*-Ac-FdC. Because of the instability of *N*-Ac-FdC in methanol, ethanol was used, wherever necessary, in column chromatography for the purification of *N*-Ac-FdC analogues.

###### Lability of *N*-Acetyl-, Benzoyl-, and Pivaloyl-FdC under Various Alkaline Conditions

  substance            pH                  temp. (°C)   half-life
  -------------------- ------------------- ------------ ---------------------------------
  *N*-Bz-FdC **6b**    11                  55           deglycosylation
  *N*-Piv-FdC **6c**   9                   55           \>60 h
  *N*-Piv-FdC **6c**   11                  55           39.2 h
  *N*-Piv-FdC **6c**   conc. aq. NH~4~OH   22           \<5 min (complete deprotection)
  *N*-Ac-FdC **6a**    9                   55           51.3 h
  *N*-Ac-FdC **6a**    11                  55           21.8 h
  *N*-Ac-FdC **6a**    conc. aq. NH~4~OH   22           \<5 min (complete deprotection)
  *N*-Ac-FdC **6a**    MeOH                22           26.7 h

Considering the stability of *N*-acetyl-FdC **6a** in acidic conditions and its ease of deprotection under alkaline conditions, *N*-Ac-FdC **6a** was used in subsequent transformations.

Solid-Phase Synthesis of d(CG)~6~ {#sec2.3}
---------------------------------

To demonstrate the utility of FdC in the structural elucidation of oligonucleotides, *N*-acetyl-FdC **6a** was incorporated into oligonucleotides by the phosphoramidite chemistry-based solid-phase synthesis. First, 5′-OH of *N*-Ac-FdC **6a** was protected with the dimethoxytrityl (DMTr) group, followed by the conversion of **7** to the corresponding phosphoramidite **8** as a mixture of two diastereomers ([Scheme [3](#sch3){ref-type="scheme"}](#sch3){ref-type="scheme"}), as indicated by ^31^P NMR spectroscopy. It was found during the purification of 5′-*O*-DMTr-*N*-4-acetyl-FdC **7** by column chromatography that the *N*-acetyl group in **6a** and **7** is labile in the presence of triethylamine; thus, diisopropylethylamine (Hünig's base), instead of triethylamine, was used to ensure the stability of **7** and **8** during column chromatography.

![Reagents and conditions: (i). DMTr-Cl, C~5~H~5~N; (ii). (CNCH~2~CH~2~O)P(Cl)N(*i*-Pr)~2~, (*i*-Pr)~2~NEt.](ao9b02461_0006){#sch3}

Six d(CG)~6~ sequences containing single FdC modification at different positions were subsequently prepared by solid-phase synthesis on an ABI DNA synthesizer on 1 μmol scales. After cleavages from solid supports and deprotection, the oligonucleotides were characterized by anion exchange HPLC and electrospray mass spectroscopy ([Table [3](#tbl3){ref-type="other"}](#tbl3){ref-type="other"}).

###### Characterization of Modified d(CG)~6~ DNA Sequences by Mass Spectroscopy (ESI, Detected for Anions), Midpoint Concentrations of NaCl for the B/Z-DNA Transition, Melting Temperatures (*T*~m~), and HPLC

                                    mass                                                    
  --------------------------------- --------- ---------------------------------- ----- ---- ----------------------------------
  d(CG)~6~/d(CGCGCGCGCGCG)                    [c](#t3fn3){ref-type="table-fn"}   2.6   82   [c](#t3fn3){ref-type="table-fn"}
  d(CG)~6~-1F/d(^F^CGCGCGCGCGCG)    3665.37   3665.5                             2.5   84   95.3
  d(CG)~6~-3F/d(CG^F^CGCGCGCGCG)    3665.37   3665.6                             2.6   86   96.3
  d(CG)~6~-5F/d(CGCG^F^CGCGCGCG)    3665.37   3665.6                             2.6   85   93.2
  d(CG)~6~-7F/d(CGCGCG^F^CGCGCG)    3665.37   3665.5                             2.4   84   94.4
  d(CG)~6~-9F/d(CGCGCGCG^F^CGCG)    3665.37   3665.5                             2.6   84   96.4
  d(CG)~6~-11F/d(CGCGCGCGCG^F^CG)   3665.37   3665.0                             2.4   83   92.1

Calculated for C~114~H~143~FN~48~O~70~P~11~^--^.

Found for mono-anion based on multiply-charged anionic species.

Purchased from IDT. ^F^C: FdC.

Characterization of the B/Z-DNA Transition in FdC-modified d(CG)~6~ by Circular Dichroism {#sec2.4}
-----------------------------------------------------------------------------------------

As one of the assumed advantages of substitution at C-5 of deoxycytidine with fluorine is its small size, minimal steric alteration is anticipated. As such, the FdC-modified d(CG)~6~ sequences were annealed in low to high concentrations of sodium chloride (0.1--4 M) and evaluated for their ability to adopt B- and Z-duplexes and transition from B- to Z-form by circular dichroism (CD), in comparison with the unmodified d(CG)~6~. As shown in [Figure [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"}, the FdC-modified d(CG)~6~ sequences show the typical CD profile for B-DNA in low concentration of sodium chloride but undergo transition gradually to the Z-form with the increase of sodium chloride concentration. In samples containing 4 M sodium chloride, all the sequences show characteristic CD profiles for Z-DNA.^[@ref13],[@ref14]^

![CD profiles of (a) unmodified d(CG)~6~; (b) d(CG)~6~-11F; and (c) d(CG)~6~-7F in varying concentrations of NaCl.](ao9b02461_0001){#fig1}

Furthermore, the absorbances of these duplexes at 260 and 290 nm were recorded, and the *A*~260~/*A*~290~ ratios were plotted to determine the midpoint concentration of sodium chloride required for the B → Z DNA transition. As shown in [Table [3](#tbl3){ref-type="other"}](#tbl3){ref-type="other"}, d(CG)~6~ sequences containing a single FdC modification have midpoint concentrations of NaCl required for B → Z-DNA transition very similar to that of the unmodified d(CG)~6~ (2.6 M), which is close to the literature value (2.5 M).^[@ref15]^ These results are in agreement with the above CD observation, confirming that FdC introduces minimal distortion to the overall DNA structures. Incorporation of FdC into d(CG)~6~ appears to slightly increase the duplex stability in the B-form, as indicated by the slightly higher melting temperature (*T*~m~ in 20 mM NaCl, [Table [3](#tbl3){ref-type="other"}](#tbl3){ref-type="other"}).

Use of FdC as a Probe to Study B → Z-DNA Transition {#sec2.5}
---------------------------------------------------

While B-type duplex is the dominant form of DNA in biological systems, the left-handed Z-DNA has been found to also exist under certain conditions, such as elevated salt concentrations and torsional stress.^[@ref14]−[@ref16]^ Despite over 40 years of investigation, numerous questions about Z-DNA remain. Of these, concrete evidence is still lacking with respect to the detailed structural changes in B → Z-transition, despite various hypotheses put forward primarily through theoretical articulation.^[@ref17]^ As ^19^F NMR shifts are quite sensitive to structural changes, this form of spectroscopy has been found to be useful in the investigation of protein and nucleic acid structures and interactions.^[@ref6]^

Examination of the ^19^F NMR spectra ([Figure [2](#fig2){ref-type="fig"}](#fig2){ref-type="fig"}a--f) of d(CG)~6~-11F reveals a clear trend of chemical shifts. In 20 mM sodium chloride, where the DNA duplex is presumed to adopt B-form DNA as indicated by the CD spectrum, two close ^19^F signals at −164.1 ppm are observed. As the concentration of sodium chloride reaches 4 M, a condition under which this duplex was established by CD spectroscopy to exist in the Z-DNA form, the ^19^F NMR signals shifted toward up-field. A gradual shift of the ^19^F resonance from −164 to −166 pm corroborates the B- to Z-transition with the increase of sodium chloride concentration from 20 mM to 4 M.

![^19^F NMR spectra of d(CG)~6~ modified with FdC \[(a--f): d(CG)~6~-11F; (a′--f′): d(CG)~6~-7F\] in the presence of varying concentrations of NaCl. (a). 4 M; (a′). 4.5 M; (b and b′). 3.0 M; (c and c′). 2.5 M; (d and d′). 2.0 M; (e and e′). 1 M; (f and f′). 20 mM. The color-coded models correspond to DNA duplexes. The bold blue arrows in the cartoons indicate unwinding of duplexes and the "bubbles" correspond to unpaired regions. Concentrations of the modified d(CG)~6~ were between 0.23 and 0.58 mM.](ao9b02461_0002){#fig2}

The changes in ^19^F NMR chemical shifts depicted in [Figure [2](#fig2){ref-type="fig"}](#fig2){ref-type="fig"}a--f support a model for the B → Z-DNA transition, where B-DNA duplex unwinds from termini as the salt concentration increases, leading to eventual switching of handedness when the salt concentration reaches a threshold value. This model is in agreement with the ^19^F NMR spectra of the d(CG)~6~-7F: d(CG)~6~ duplex ([Figure [2](#fig2){ref-type="fig"}](#fig2){ref-type="fig"}a′--f′), which was annealed by mixing d(CG)~6~-7F and d(CG)~6~ in a 1:5 ratio. In this case, changes in ^19^F shifts only became significant when sodium chloride concentration reaches 3 M ([Figure [2](#fig2){ref-type="fig"}](#fig2){ref-type="fig"}c′), further supporting the scenario where unwinding of interior occurs after the duplex unwinds at the termini.

Further investigation of the FdC-modified d(CG)~6~ by ^1^H NMR revealed that incorporation of FdC appears to affect hydrogen bonds. As shown in the ^1^H NMR of unmodified d(CG)~6~ and those modified with FdC at 7 and 11 positions ([Figure [3](#fig3){ref-type="fig"}](#fig3){ref-type="fig"}, samples were prepared in H~2~O--D~2~O, 9:1 v/v, at 0.4 mM), the NH protons in the most downfield region that are typically found in hydrogen bonding display different chemical shifts, suggesting disruptions to hydrogen bonding by FdC.

![^1^H NMR of (a). d(CG)~6~-11F, (b). (d). d(CG)~6~-7F, and (c). d(CG)~6~ in H~2~O/D~2~O (9:1, v/v). Oligonucleotides were annealed in Tris-HCl (10 mM, pH 7.5 containing 20 mM NaCl) at a 0.4 mM (ssDNA) concentration.](ao9b02461_0003){#fig3}

Conclusions {#sec3}
===========

FdC **5** was successfully synthesized from FdU **1**. *N*-Acetyl was found to be a suitable protecting group for FdC for the incorporation of this modified nucleoside into oligonucleotides through the phosphoramidite chemistry-based solid-phase synthesis. Compared with unmodified d(CG)~6~, oligonucleotides containing a single FdC modification showed very little difference in CD profiles both in the B- and Z-forms, indicating minimal distortions of DNA duplexes by this fluorinated nucleoside. ^19^F NMR spectroscopy of d(CG)~6~ duplexes containing FdC at varying sodium chloride concentrations suggested that B → Z-DNA transition is likely initiated by the unwinding of duplex at termini, leading to switches of handedness with the increase of sodium chloride concentration.

Overall, FdC has the potential to be used as a versatile probe for DNA structures and interactions with other molecules. The possibility of disruptions to hydrogen bonding by FdC should, however, be considered.

Methods {#sec4}
=======

Instrumentation {#sec4.1}
---------------

^1^H NMR spectra were recorded at 400 or 600 MHz with Bruker AVANCE 400 and 600 NMR spectrometers with 14.1 and 7.05 T Ultrashield magnets, respectively. ^13^C NMR spectra were measured at 100.6 MHz, ^31^P NMR at 162.0 MHz, and ^19^F at 376.6 or 564.7 MHz with the same spectrometers. Coupling constants (*J*) and chemical shifts are given in ppm and hertz (Hz), respectively. Deuterated solvents were purchased from C/D/N Inc. EI (electron impact) and FAB (fast atom bombardment) mass spectra were obtained with a Thermo Scientific DFS mass spectrometer; ESI (electrospray) spectra were measured with a Bruker HCT Plus ion-trap mass spectrometer. Circular Dichroism spectra were recorded using a Jasco J-600 Circular Dichroism Spectrometer.

Chromatography {#sec4.2}
--------------

Desican silica gel (230--400 mesh) was used for flash chromatography. Thin layer chromatography (TLC) was performed on Silicycle Silica plate F-254 TLC plates using the following solvent mixtures:

Solvent A: methanol/dichloromethane (5:95, v/v).

Solvent B: methanol/dichloromethane (10:90, v/v).

Solvent C: methanol/dichloromethane (20:80, v/v).

HPLC was conducted with a Dionex 3000 Ionic Chromatography system. Reverse-phase Acclaim PA columns (4.6 × 150 mm, C18, 3 μm) were eluted with water/acetonitrile mixtures at a flow rate of 0.7 mL/min. Anion-exchange high-performance liquid chromatography was carried out on a DNAPac 200 column (4 × 250 mm) using a denaturing elution condition (containing 4 M urea at pH 12.4 and linear gradient elution with NaCl).^[@ref18]^

Solvents and Chemicals {#sec4.3}
----------------------

Toluene was dried by heating under reflux over sodium metal in the presence of benzophenone for 4 h and then distilled. *N*,*N*-Diisopropylethylamine, *N*,*N*-dimethylformamide, *N*-methylpyrrolidine, pyridine, and acetonitrile were dried by heating over calcium hydride and then distilled. Dichloromethane was dried by heating under reflux over phosphorus pentoxide and then distilled. All other reagents were purchased from Sigma-Aldrich or TCI without further purification prior to use unless stated otherwise.

Oligonucleotide Synthesis {#sec4.4}
-------------------------

Oligonucleotides were synthesized using an ABI 3400 DNA synthesizer on 1 μmol scales using the standard 1 μmol cycle conditions. Phosphoramidites were prepared as 100 mM solutions in dry acetonitrile. 5-(Ethylthio)-1*H*-tetrazole (250 mM in dry acetonitrile) was used as the activator and coupling reactions were allowed for 60 s. Detritylation was carried out by delivering trichloroacetic acid (3% in dichloromethane) for 110 s. After the solid-phase synthesis was complete, the products were incubated with concentrated aqueous ammonium hydroxide (28%) at 55 °C for 14 h. After lyophilization, the products were passed through Amberlite IR120 resin in the sodium form. The products were found by anion exchange HPLC to contain 92--96% full length sequences.

Synthesis of 5-Fluoro-2′-deoxycytidine **5** {#sec4.5}
--------------------------------------------

5-Fluoro-2′-deoxyuridine **1** (5.00 g, 20.3 mmol) was dried under vacuum at 70 °C for 3 h and then suspended in dry acetonitrile (150 mL). Chlorotrimethylsilane (7.76 mL, 60.9 mmol), followed by *N*-methylpyrrolidine (16.86 mL, 0.163 mol) were added, and the reaction mixture was stirred for 1 h at room temperature; upon cooling (ice-water bath), trifluoroacetic anhydride (8.47 mL, 60.9 mmol) was added dropwise over 5 min. After 30 min, 2,4,6-trimethylphenol (8.30 g, 60.9 mmol) was added and the reaction mixture was stirred at 0 °C for 3 h. Aqueous ammonium hydroxide (25 mL, 28%) was added and the flask was sealed and heated at 65 °C for 24 h. Upon cooling, the products were evaporated to dryness under reduced pressure, and the residue was purified by column chromatography on silica gel. The appropriate fractions, which were eluted with dichloromethane/methanol (93:7 v/v), were combined and concentrated under reduced pressure to give the *title compound* as a pale orange solid (2.98 g, 60%). The starting material **1** (1.80 g, 36%) was also recovered. *R*~f~ (System C): 0.28. HR-MS (EI) found 245.0806, C~9~H~12~FN~3~O~4~ required 245.0812. δ~H~ (DMSO-*d*~6~): 1.98 (1H, H-2′, ddd, *J* = 6.0, 7.0 and 13.3), 2.12 (1H, H-2″, ddd, *J* = 3.5, 6.0 and 13.3), 3.58 (2H, H-5′ and H-5″, m), 3.77 (1H, H-4′, ddd, *J* = 3.4, 3.4 and 3.4), 4.21 (1H, H-3′, m), 5.09 (1H, 5′-OH, dd, *J* = 4.9 and 4.9, ex), 5.20 (1H, 3′-OH, d, *J* = 4.2, ex), 6.11 (1H, H-1′, ddd, *J* = 2.0 (^5^*J*~F,H~), 6.0 and 7.4), 7.49 (1H, NH~2~, s, ex), 7.73 (1H, NH~2~, s, ex), 8.08 (1H, H-6, d, ^3^*J*~F,H~ = 7.3). δ~C~ (DMSO-*d*~6~): 40.9, 61.5, 70.6, 85.6, 87.7, 125.6, 126.0, 135.3, 135.7, 153.8, 157.7, 157.9. δ~F~ (DMSO-*d*~6~): −167.3.

Synthesis of *N*-Acetyl-5-fluoro-2′-deoxycytidine **6a** {#sec4.6}
--------------------------------------------------------

To a solution of 5-fluoro-2′-deoxycytidine **5** (1.00 g, 4.08 mmol) in dry pyridine (20 mL), chlorotrimethylsilane (2.0 mL, 15.8 mmol) was added. After 30 min, acetyl chloride (0.44 mL, 6.2 mmol) was added and the reaction mixture was stirred at room temperature for 4 h. The products were chilled (ice-water bath). Water was added until all salts dissolved, followed by addition of triethylamine (2.85 mL, 20.4 mmol). The products were stirred at room temperature for 30 min and then evaporated to dryness under reduced pressure. The residue was purified by column chromatography on silica gel. The appropriate fractions, which were eluted with dichloromethane/ethanol (97:3 v/v), were combined and concentrated under reduced pressure to give the *title compound* as a yellow solid (0.85 g, 73%). *R*~f~ (System B): 0.12. HR-MS (EI) found 287.0909, C~11~H~14~FN~3~O~5~ required 287.0918. δ~H~ (DMSO-*d*~6~): 2.08 (1H, H-2′, ddd, *J* = 6.2, 6.2 and 13.3), 2.22 (3H, N--Ac, s) 2.28 (1H, H-2″, ddd, *J* = 4.4, 6.3 and 13.3), 3.59 (1H, H-5′, ddd, *J* = 3.4, 3.8 and 12.0), 3.67 (1H, H-5″, ddd, *J* = 3.4, 3.8 and 12.0), 3.85 (1H, H-4′, ddd, *J* = 3.4, 3.4 and 3.4), 4.24 (1H, H-3′, m), 5.20 (1H, 5′-OH, t, *J* = 4.4, ex), 5.27 (1H, 3′-OH, d, *J* = 3.8, ex), 6.05 (1H, H-1′, ddd, *J* = 1.2, 6.2 and 6.2), 8.51 (1H, H-6, d, *J* = 6.6), 10.59 (1H, NH, s, br, ex). δ~C~ (DMSO-*d*~6~): 25.1, 41.2, 61.0, 69.9, 86.7, 88.3, 130.2 (d, C-6, ^2^*J*~F,C~ = 34.5), 137.5 (d, C-5, ^1^*J*~F,C~ = 240.7), 152.7, 153.7, 170.3. δ~F~ (DMSO-*d*~6~): −158.3.

Synthesis of *N*-Benzoyl-5-fluoro-2′-deoxycytidine **6b** {#sec4.7}
---------------------------------------------------------

To a solution of 5-fluoro-2′-deoxycytidine **5** (0.200 g, 0.82 mmol) in dry pyridine (4 mL), chlorotrimethylsilane (0.42 mL, 3.31 mmol) was added. After 30 min, benzoyl chloride (0.17 mL, 1.46 mmol) was added and the reaction mixture was stirred at room temperature for 4 h. The products were chilled (ice-water bath). Water was added until all salts dissolved, followed by addition of triethylamine (0.57 mL, 4.1 mmol). The mixture was stirred at room temperature for 30 min and then evaporated under reduced pressure. The residue was purified by column chromatography on silica gel. The appropriate fractions, which were eluted with dichloromethane/ethanol (97:3 v/v), were combined and concentrated under reduced pressure to give the *title compound* as a white solid (194 mg, 68%). *R*~f~ (System B): 0.24. HR-MS (EI) found 349.1066, C~16~H~16~FN~3~O~5~ required 349.1074. δ~H~ (D~2~O): 2.28 (1H, H-2′, ddd, *J* = 6.1, 6.2 and 14.1), 2.46 (1H, H-2″, ddd, *J* = 4.7, 6.2 and 14.1), 3.71 (1H, H-5′, dd, *J* = 4.8 and 12.5), 3.80 (1H, H-5″, dd, *J* = 3.4 and 12.5), 4.03 (1H, H-4′, ddd, *J* = 4.3, 4.4 and 4.7), 4.37 (1H, H-3′, ddd, *J* = 4.4, 4.4 and 6.2), 6.17 (1H, H-1′, dd, *J* = 6.2 and 6.2), 7.46 (2H, t, *J* = 7.3), 7.56 (1H, t, *J* = 7.3), 7.85 (2H, d, *J* = 7.3), 8.14 (1H, H-6, br). δ~F~ (D~2~O): −156.7 (br).

Synthesis of *N*-Pivaloyl-5-fluoro-2′-deoxycytidine **6c** {#sec4.8}
----------------------------------------------------------

To a solution of 5-fluoro-2′-deoxycytidine **5** (0.200 g, 0.82 mmol) in dry pyridine (4 mL), chlorotrimethylsilane (0.42 mL, 3.31 mmol) was added. After 30 min, pivaloyl chloride (0.15 mL, 1.22 mmol) was added and the reaction mixture was stirred at room temperature for 4 h. The products were cooled (ice-water bath). Water was added until all salts dissolved, followed by addition of triethylamine (0.57 mL, 4.1 mmol). After stirring at room temperature for 30 min, the products were evaporated to dryness under reduced pressure. The residue was purified by column chromatography on silica gel. The appropriate fractions, which were eluted with dichloromethane/ethanol (98:2 v/v), were combined and concentrated under reduced pressure to give the *title compound* as a pale green solid (190 mg, 70%). *R*~f~ (system B): 0.30. HR-MS (EI) found 329.1381, C~14~H~20~FN~3~O~5~ required 329.1387. δ~H~ (DMSO-*d*~6~): 1.19 (9H, −(CH~3~)~3~, s), 2.11 (1H, H-2′, ddd, *J* = 6.2, 6.2 and 12.2), 2.27 (1H, H-2″, m), 3.59 (1H, H-5′, ddd, *J* = 3.7, 4.7 and 12.0), 3.67 (1H, H-5″, ddd, *J* = 3.6, 5.1 and 12.0), 3.85 (1H, H-4′, ddd, *J* = 3.5, 3.5 and 3.5), 4.25 (1H, H-3′, m), 5.21 (1H, 5′-OH, t, *J* = 4.9, ex), 5.29 (1H, 3′-OH, d, *J* = 4.4, ex), 6.05 (1H, H-1′, ddd, *J* = 1.3, 6.2 and 6.2), 8.48 (1H, H-6, s, br), 10.5 (1H, −NH, s, br, ex). δ~C~ (DMSO-*d*~6~) include the following signals: 27.2, 41.1, 61.1, 70.0, 86.6, 88.3, 138.0, 140.4. δ~F~ (DMSO-*d*~6~): −153.3.

Synthesis of *N*-Acetyl-5-fluoro-5′-(4,4′-dimethoxytrityl)-2′-deoxycytidine 7 {#sec4.9}
-----------------------------------------------------------------------------

*N*-Acetyl-5-fluoro-2′-deoxycutidine **6a** (1.70 g, 5.92 mmol) was co-evaporated with dry pyridine (3 × 10 mL) and then taken up in dry pyridine (15 mL), followed by addition of 4,4′-dimethoxytrityl chloride (3.00 g, 8.85 mmol). After the reaction mixture was stirred at room temperature for 45 min, a triethylamine/ethanol (1:1 v/v) mixture (3.5 mL) was added. The products were diluted with dichloromethane (100 mL) and extracted with saturated aqueous sodium bicarbonate (35 mL). The layers were separated and the aqueous layer was back-extracted with dichloromethane (30 mL). The combined organic layers were dried (MgSO~4~) and evaporated to dryness. The oily residue was purified by column chromatography on silica gel. The appropriate fractions, which were eluted with dichloromethane/ethanol/triethylamine (98.2:1.5:0.3 v/v/v), were combined and concentrated under reduced pressure to give the *title compound* as a light pink solid (2.96 g, 85%). *R*~f~ (system A): 0.28. HR-MS (EI) found 589.2217, C~32~H~32~FN~3~O~7~ required 589.2224. δ~H~ (DMSO-*d*~6~): 2.16--2.23 (4H, H-2′ and −CH~3~ (acetyl), m), 2.34 (1H, H-2″, ddd, *J* = 4.8, 6.5 and 11.5), 3.20 (1H, H-5′, dd, *J* = 2.7 and 10.2), 3.27 (1H, H-5″, dd, *J* = 5.4 and 10.6), 3.74 (6H, −(OCH~3~)~2~, s), 3.98 (1H, H-4′q, *J* = 4.5), 4.27 (1H, H-3′, m), 5.37 (1 H, 3′-OH, d, *J* = 4.6, ex), 6.06 (1H, H-1′, t, *J* = 5.8), 6.90 (4H, d, *J* = 8.8), 7.23--7.40 (9H, m), 8.15 (1H, H-6, d, *J* = 6.3), 10.5 (1H, −NH, s, br, ex). δ~F~ (DMSO-*d*~6~): −158.6.

Synthesis of *N*-Acetyl-5-fluoro-5′-(4,4′-dimethoxytrityl)-2′-deoxycytidine-3′-(2-cyanoethyl)-*N*,*N*-diisopropylphosphoramidite 8 {#sec4.10}
----------------------------------------------------------------------------------------------------------------------------------

*N*-Acetyl-5-fluoro-5′-(4,4′-dimethoxytrityl)-2′-deoxycitidine **7** (1.00 g, 1.70 mmol) was co-evaporated with dry toluene (3 × 10 mL) and then dissolved in dry dichloromethane (20 mL). Dry *N*,*N*-diisopropylethylamine (1.5 mL, 8.6 mmol), followed by (2-cyanoethyl)-*N*,*N*-diisopropyl phosphochloridite (0.66 g, 2.8 mmol) were added, and the reaction mixture was stirred at room temperature for 30 min. *N*,*N*-Diisopropylethylamine (1.0 mL) was added and the products were evaporated under reduced pressure. The residue was purified by column chromatography on silica gel. The appropriate fractions, which were eluted with hexane/acetone/*N*,*N*-diisopropylethylamine (70:28:2 v/v), were combined and concentrated under reduced pressure. The residue was dissolved in dichloromethane (2 mL) and added dropwise to pentane (20 mL) at −40 °C under stirring. Cloudy suspension was centrifuged for 20 min and the supernatant was decanted. The white solid was collected and dried to give the *title compound* as a colorless solid (0.86 g, 64%). *R*~f~ (System A): 0.41. HR-MS (ESI) found 790.3381 (M -- H^+^), C~41~H~49~FN~5~O~8~P required 789.3303. δ~H~ (CDCl~3~): 1.12 (3H, CH~3~, (*i*-Pr), d, *J* = 6.8), 1.19--1.21 (9H, −CH~3~ (*i*-Pr), m), 2.38 (1H, H-2′, ddd, *J* = 6.8, 6.8 and 13.8), 2.50 (1H, CH~2~, t, *J* = 6.3), 2.65 (1H, CH~2~, *J* = 8.3), 2.71 (3H, CH~3~ (acetyl) s), 2.66 (4H, P(CH2)2CN, m), 2.81 (1H, H-2″, m), 3.42--3.47 (2H, H-5′, H-5″, m), 3.57--3.65 (2H, 2xCH (*i*-Pr), m), 3.67--3.78 (1H, CH~2~, m), 3.81 (3H, −OMe, s), 3.82 (3H, −OMe, m), 3.84--3.92 (1H, CH~2~, m), 4.21--4.27 (1H, H-4′, m), 4.66--4.74 (1H, H-3′, m), 6.17--6.22 (1H, H-1′, m), 6.83--6.87 (4H, m), 7.23--7.33 (Ar, m, overlap with CHCl~3~ residue signals), 7.40--7.42 (2H, m), 7.62 (1H, NH, s, br), 8.19 and 8.24 (integrate 1H, H-6, each as d, ^3^*J*~F,H~ = 5.5). δ~F~ (CDCl~3~): −166.4. δ~P~ (CDCl~3~): 148.8 and 149.2.

Circular Dichroism Spectroscopy {#sec4.11}
-------------------------------

CD samples were prepared by dissolving oligonucleotides (10 μM) in Tris-HCl buffer (10 mM, pH 7.5) and NaCl (0.02--4 M) in autoclaved miliQ water. Oligonucleotides were annealed on a Mastercycler Nexus gradient thermal cycler by heating to 95 °C over 10 min followed by slow cooling to 25 °C over a period of 50 min.

UV/Vis Spectroscopy {#sec4.12}
-------------------

The absorbance of annealed oligonucleotides was measured at 260 and 290 nm on a Genesys 10S UV--Vis Spectrophotometer. Samples were prepared in the same manner as those used for CD measurement.

*T*~m~ Measurement {#sec4.13}
------------------

Oligonucleotides were prepared at 5 μM (ssDNA) in Tris-HCl buffer (10 mM, pH 7.5, containing 20 mM NaCl) annealed in a Mastercycler Nexus gradient thermal cycler by first heating to 95 °C, followed by slow cooling to 25 °C over a period of 35 min. Melting temperatures were measured using a Cary 3000 UV/vis spectrophotometer. The temperature was increased by 1 °C/min.

^19^F NMR Spectroscopy {#sec4.14}
----------------------

An appropriate amount of oligonucleotides with sodium cations was reconstituted in a Tris-HCl buffer (10 mM, pH 7.5, 0.5 mL in deuterium oxide) containing appropriate concentration of NaCl (0.02--4 M) and 0.01 μM of sodium trifluoroacetate (as an internal standard for ^19^F NMR). ^19^F NMR spectra were processed by applying the linear backward prediction algorithm in order to eliminate background signals from NMR tubes.^[@ref19]^
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